Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Texas was posted on September 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Gene infusions therapy

Awarded
UCLIN-0000620304State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210
New
International
33600000-6 Фармацевтична продукція, Лікарські засоби, Thiopental (Тіопентал)
Solicitation # UA-2026-11-06-015035-a
This contract concerns the supply of pharmaceutical products, specifically Thiopental, to the Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov in Dnipro, Ukraine. The delivery period extends from the date of signing until December 15, 2026. The supplier is responsible for transporting and unloading the goods to the first and second floors of the hospital warehouse, ensuring all items are packaged and transported according to pharmaceutical standards to prevent damage. All deliveries must be accompanied by required legal documentation, including registration certificates, quality certificates, and invoices that specify wholesale prices and retail margins in compliance with Ukrainian government regulations. Payment is made via bank transfer with a standard deferred payment term of up to 30 calendar days. However, if funding from the National Health Service of Ukraine is delayed, payment will be processed within three working days of the hospital receiving the funds. Risk of loss transfers to the buyer upon the signing of the delivery note.
КОМУНАЛЬНЕ НЕКОМЕРЦІЙНЕ ТОВАРИСТВО «ДНІПРОПЕТРОВСЬКА ОБЛАСНА КЛІНІЧНА ЛІКАРНЯ ІМ. І.І. МЕЧНИКОВА» ДНІПРОПЕТРОВСЬКОЇ ОБЛАСНОЇ РАДИ»

POSTED

2 days ago

DEADLINE

in 2 days

AI Contract Overview

Show more

The University of Texas Medical Branch at Galveston has entered into a contract with Cura Script Specialty Distribution for the procurement of Zolgensma gene infusions therapy. This award, identified by solicitation number UCLIN-0000620304, is valued at 2,086,043.18 dollars. The contract term is established from July 22, 2025, through July 21, 2027, with a response deadline noted for August 31, 2027. The procurement is classified under NAICS code 424210 and has been certified for compliance by executive leadership. A critical component of this agreement is the risk assessment, which identifies Cura Script Specialty Distribution as the sole approved distributor for this specific gene therapy treatment. This contract was formally reported to the Legislative Budget Board to ensure transparency and adherence to state procurement standards.

General Info

Contract Value

$2,086,043

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

1
PDF, Low priorityjustification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyThe University of Texas Medical Branch at Galveston
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS